ToxSci Advance Access published online on March 20, 2006
Toxicological Sciences, doi:10.1093/toxsci/kfj165
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1 Department of Pharmacology and Biological Chemistry, Mount Sinai School of Medicine, New York, New York 10029
* To whom correspondence should be addressed. Induction of cytochrome P450 2E1 by ethanol is believed to be one of the central pathways by which ethanol generates a state of oxidative stress and causes hepatotoxicity. In order to evaluate the biochemical and toxicological actions of CYP2E1 and its sensitization of hepatotoxin-induced injury, an adenovirus which can mediate overexpression of CYP2E1 was constructed. Injecting this virus into mice through the tail vein elevated CYP2E1 protein and activity 2 fold in the liver of the mice compared with the mice injected with Ad-LacZ or saline. Transaminase levels were dramatically increased in mice injected with the CYP2E1 adenovirus. Histological evaluation of liver specimens of mice injected with Ad-2E1 showed liver cell injury. TUNEL assay demonstrated that more cells were stained positively in the liver of the mice infected with Ad-2E1 than in the liver of the mice infected with Ad-LacZ. 3-Nitrotyrosine protein adducts and protein carbonyl adducts were increased in the liver of the mice infected with Ad-2E1 compared with Ad-LacZ. This potentiated toxicity most likely reflects interactions between CYP2E1-and adenovirus-mediated toxicity pathways. These results show that adenovirus mediated overexpression of CYP2E1 could induce liver toxicity in mice, and suggests a mechanism involving oxidative / nitrosative stress.
Received January 18, 2006
Accepted March 13, 2006
Genetic Toxicology
Adenovirus-Mediated Expression of CYP2E1 Produces Liver Toxicity in Mice
Jingxiang Bai 1 *
and
Arthur I Cederbaum 1
Jingxiang Bai, E-mail: Jingxiang.Bai{at}mssm.edu
![]()
Abstract ![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
J. R. Roede, D. J. Orlicky, A. B. Fisher, and D. R. Petersen Overexpression of Peroxiredoxin 6 Does Not Prevent Ethanol-Mediated Oxidative Stress and May Play a Role in Hepatic Lipid Accumulation J. Pharmacol. Exp. Ther., July 1, 2009; 330(1): 79 - 88. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Anderson and J. Borlak Molecular Mechanisms and Therapeutic Targets in Steatosis and Steatohepatitis Pharmacol. Rev., September 1, 2008; 60(3): 311 - 357. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Dostalek, J. D. Brooks, K. D. Hardy, G. L. Milne, M. M. Moore, S. Sharma, J. D. Morrow, and F. P. Guengerich In Vivo Oxidative Damage in Rats Is Associated with Barbiturate Response but Not Other Cytochrome P450 Inducers Mol. Pharmacol., December 1, 2007; 72(6): 1419 - 1424. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Mori, P. E. Blackshear, E. K. Lobenhofer, J. S. Parker, D. P. Orzech, J. H. Roycroft, K. L. Walker, K. A. Johnson, T. A. Marsh, R. D. Irwin, et al. Hepatic Transcript Levels for Genes Coding for Enzymes Associated with Xenobiotic Metabolism are Altered with Age Toxicol Pathol, February 1, 2007; 35(2): 242 - 251. [Abstract] [Full Text] [PDF] |
||||



